1. DIPG-07. Preclinical and case study results underpinning the phase II clinical trial testing the combination of ONC201 and paxalisib for the treatment of patients with diffuse midline glioma (NCT05009992). (3rd June 2022) Authors: Dun, Matthew D; Jackson, Evangeline R; Duchatel, Ryan J; Persson, Mika L; Mannan, Abdul; Yadavilli, Sridevi; Parackal, Sarah; Game, Shaye; Chong, Wai Chin; Jayasekara, Samantha; Le Grand, Marion; Kearney, Padraic S; Douglas, Alicia M; Findlay, Izac J; Staudt, Dilana; Germon, Zacary P; Skerrett-By... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 1 Page Start: i18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EXTH-12. PRECLINICAL AND CASE STUDY EXAMINATION OF THE COMBINATION OF THE CLPP AGONIST ONC201 WITH THE PI3K/AKT INHIBITOR PAXALISIB FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA. (14th November 2022) Authors: Jackson, Evangeline; Duchatel, Ryan; Persson, Mika; Mannan, Abdul; Yadavilli, Sridevi; Parackal, Sarah; Game, Shaye; Chong, Wai Chin; Jayasekara, Samantha; Le Grand, Marion; Kearney, Padraic; Douglas, Alicia; Findlay, Izac; Staudt, Dilana; Germon, Zacary; Skerrett-Byrne, David; Nixon, Brett; Smit... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗